| 臺大學術典藏 |
2022-09-15T01:08:57Z |
Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors
|
Strickler J.H.; LoRusso P.; Salgia R.; Kang Y.-K.; Yen C.J.; Chia-Chi Lin; Ansell P.; Motwani M.; Wong S.; Yue H.; Wang L.; Reilly E.; Afar D.; Naumovski L.; Ramanathan R.K. |
| 臺大學術典藏 |
2021-09-15T01:20:56Z |
Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer
|
Jen J.; Lin L.-L.; Chen H.-T.; Liao S.-Y.; Lo F.-Y.; Tang Y.-A.; Su W.-C.; Salgia R.; CHIA-LANG HSU; Huang H.-C.; Juan H.-F.; Wang Y.-C. |
| 臺大學術典藏 |
2021-09-15T01:20:54Z |
Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369))
|
Jen J.; Lin L.-L.; Lo F.-Y.; Chen H.-T.; Liao S.-Y.; Tang Y.-A.; Su W.-C.; Salgia R.; CHIA-LANG HSU; Huang H.-C.; Juan H.-F.; Wang Y.-C. |
| 臺大學術典藏 |
2021-07-26T10:04:08Z |
Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369))
|
Jen J;Lin L.-L;Lo F.-Y;Chen H.-T;Liao S.-Y;Tang Y.-A;Su W.-C;Salgia R;Hsu C.-L;Huang H.-C;Juan H.-F;Wang Y.-C.; Jen J; HSUEH-FEN JUAN et al. |
| 臺大學術典藏 |
2020-05-26T09:27:15Z |
Phase 2 trial of linifanib (ABT-869) in patients with advanced non-small cell lung cancer
|
Hensing T; Lee C; Gupta N; Pradhan R; Qian J; Qin Q; Scappaticci F.A; Ricker J.L; Carlson D.M; Soo R.A.; Tan E.-H;Goss G.D;Salgia R;Besse B;Gandara D.R;Hanna N.H;Chih-Hsin Yang;Thertulien R;Wertheim M;Mazieres J;Hensing T;Lee C;Gupta N;Pradhan R;Qian J;Qin Q;Scappaticci F.A;Ricker J.L;Carlson D.M;Soo R.A.; Tan E.-H; Goss G.D; Salgia R; Besse B; Gandara D.R; Hanna N.H; CHIH-HSIN YANG; Thertulien R; Wertheim M; Mazieres J |
| 臺大學術典藏 |
2020-05-25T07:35:15Z |
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
|
Reynolds K.L; Bedard P.L; Lee S.-H; Chia-Chi Lin; Tabernero J; Alsina M; Cohen E; Baselga J; Blumenschein G; Graham D.M; Garrido-Laguna I; Juric D; Sharma S; Salgia R; Seroutou A; Tian X; Fernandez R; Morozov A; Sheng Q; Ramkumar T; Zubel A; Bang Y.-J. |
| 臺大學術典藏 |
2020-05-25T07:35:00Z |
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors
|
Ansell P; Motwani M; Wong S; Yue H; Wang L; Reilly E; Afar D; Naumovski L; Ramanathan R.K.; Strickler J.H; LoRusso P; Salgia R; Kang Y.-K; Yen C.J; Chia-Chi Lin |
| 國立成功大學 |
2020 |
Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors
|
Strickler, J.H.;LoRusso, P.;Salgia, R.;Kang, Y.-K.;Yen, C.J.;Lin, C.-C.;Ansell, P.;Motwani, Motwani M.;Wong, S.;Yue, H.;Wang, L.;Reilly, E.;Afar, D.;Naumovski, L.;Ramanathan, Ramanathan R.K. |
| 臺大學術典藏 |
2018-09-10T07:27:24Z |
Molecular cloning and characterization of human trabeculin-α, a giant protein defining a new family of actin-binding proteins
|
Zhang, J.; Kraeft, S.-K.; Auclair, D.; Chang, M.-S.; Liu, Y.; Sutherl; , R.; Salgia, R.; Griffin, J.D.; Ferl; , L.H.; Chen, L.B.; Sun, Y.; MAU-SUN CHANG et al. |
| 國立成功大學 |
2016-05-05 |
Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer
|
Jen, J.; Lin, L-L; Chen, H-T; Liao, S-Y; Lo, F-Y; Tang, Y-A; Su, W-C; Salgia, R.; Hsu, C-L; Huang, H-C; Juan, H-F; Wang, Y-C |
